These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10671971)

  • 1. Epidermodysplasia verruciformis: association with isolated IgM deficiency and response to treatment with acitretin.
    Iraji F; Faghihi G
    Clin Exp Dermatol; 2000 Jan; 25(1):41-3. PubMed ID: 10671971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermodysplasia verruciformis with multiple mucosal carcinomas treated with pegylated interferon alfa and acitretin.
    Gubinelli E; Posteraro P; Cocuroccia B; Girolomoni G
    J Dermatolog Treat; 2003 Sep; 14(3):184-8. PubMed ID: 14522631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of epidermodysplasia verruciformis with squamous cell carcinomas on non-sun-exposed areas of skin.
    Ansarin H; Tajziehchi L; Shaianfar N
    Arch Iran Med; 2007 Apr; 10(2):261-3. PubMed ID: 17367237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of epidermodysplasia verruciformis with a combination of acitretin and interferon alfa-2a.
    Anadolu R; Oskay T; Erdem C; Boyvat A; Terzi E; Gürgey E
    J Am Acad Dermatol; 2001 Aug; 45(2):296-9. PubMed ID: 11464195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained clinical resolution of acquired epidermodysplasia verruciformis in an immunocompromised patient after discontinuation of oral acitretin with topical imiquimod.
    Nijhawan RI; Osei-Tutu A; Hugh JM
    J Drugs Dermatol; 2013 Mar; 12(3):348-9. PubMed ID: 23545921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inherited Interleukin 2-Inducible T-Cell (ITK) Kinase Deficiency in Siblings With Epidermodysplasia Verruciformis and Hodgkin Lymphoma.
    Youssefian L; Vahidnezhad H; Yousefi M; Saeidian AH; Azizpour A; Touati A; Nikbakht N; Hesari KK; Adib-Sereshki MM; Zeinali S; Mansoori B; Jazayeri A; Karamzadeh R; Fortina P; Jouanguy E; Casanova JL; Uitto J
    Clin Infect Dis; 2019 May; 68(11):1938-1941. PubMed ID: 30778533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of acquired epidermodysplasia verruciformis in a renal transplant recipient clearing with multimodal treatment including HPV (Gardasil) vaccination.
    Maor D; Brennand S; Goh MS; Fahey V; Tabrizi SN; Chong AH
    Australas J Dermatol; 2018 May; 59(2):147-148. PubMed ID: 28718200
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of Imiquimod Resistant Epidermodysplasia Verruciformis With Ingenol Mebutate.
    Kim C; Hashemi P; Caglia M; Shulman K
    J Drugs Dermatol; 2016 Mar; 15(3):350-2. PubMed ID: 26954321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermodysplasia verruciformis associated with isolated IgM deficiency.
    Gul U; Soylu S; Yavuzer R
    Indian J Dermatol Venereol Leprol; 2007; 73(6):420-2. PubMed ID: 18032865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired epidermodysplasia verruciformis in a child with atopic dermatitis.
    Fernandez KH; Rady P; Tyring S; Stone MS
    Pediatr Dermatol; 2014; 31(3):400-2. PubMed ID: 22938530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired epidermodysplasia verruciformis: clinical presentation and treatment update.
    Moore S; Rady P; Tyring S
    Int J Dermatol; 2022 Nov; 61(11):1325-1335. PubMed ID: 34403500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired Epidermodysplasia Verruciformis in the Setting of Renal Transplant.
    Henning A; Weaver J; Reedy M
    Am J Dermatopathol; 2021 Jan; 43(1):71-74. PubMed ID: 32568838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acitretin treatment in acrokeratosis verruciformis of Hopf.
    Serarslan G; Balci DD; Homan S
    J Dermatolog Treat; 2007; 18(2):123-5. PubMed ID: 17520472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acitretin for lichen amyloidosus.
    Choi JY; Sippe J; Lee S
    Australas J Dermatol; 2008 May; 49(2):109-13. PubMed ID: 18412814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acitretin in management of diffuse common warts: a case report.
    Proietti I; Skroza N; Bernardini N; Nicolucci F; Tolino E; La Viola G; Orsini D; Zuber S; Potenza C
    Dermatol Ther; 2011; 24(6):581-3. PubMed ID: 22515673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple keratoacanthomas in a young woman: report of a case emphasizing medical management and a review of the spectrum of multiple keratoacanthomas.
    Feldman RJ; Maize JC
    Int J Dermatol; 2007 Jan; 46(1):77-9. PubMed ID: 17214727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermodysplasia verruciformis: successful treatment with squaric acid dibutylester.
    Kehdy J; Erickson C; Rady P; Tyring S; Gaspari AA
    Cutis; 2015 Aug; 96(2):114-8. PubMed ID: 26367749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of acitretin in the treatment of resistant viral warts.
    El-Khayat RH; Hague JS
    J Dermatolog Treat; 2011 Aug; 22(4):194-6. PubMed ID: 20443666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural cell-mediated cytotoxicity against various target cells in patients with epidermodysplasia verruciformis.
    Majewski S; Malejczyk J; Jablonska S; Misiewicz J; Rudnicka L; Obalek S; Orth G
    J Am Acad Dermatol; 1990 Mar; 22(3):423-7. PubMed ID: 2155952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifocal leiomyosarcomatosis in a 6-year-old child with epidermodysplasia verruciformis and immune defect.
    Boybeyi O; Akçören Z; Oğuz B; Akyüz C; Sanal O; Ergin S; Ersoy-Evans S; Tanyel FC
    J Pediatr Surg; 2009 Jul; 44(7):e5-8. PubMed ID: 19573649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.